» Articles » PMID: 21833575

Anaplastic Ependymoma Simulating Glioblastoma in the Cerebrum of an Adult

Overview
Date 2011 Aug 12
PMID 21833575
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A case of anaplastic ependymoma of the cerebral hemisphere in which the histopathological features closely simulated those of glioblastoma is reported. The patient was a 72-year-old woman with a large, well-demarcated tumor in the left temporal lobe. The tumor was totally extirpated, but recurred 18 months later, and the patient died after 4 months. The extirpated tumor was well circumscribed from the surrounding brain tissue and consisted of a sheet-like, dense proliferation of atypical, short spindle or polygonal cells. Extensive geographic necrosis with nuclear pseudopalisading was seen. Although perivascular pseudorosettes were observed in many areas, true ependymal rosettes were absent. Immunohistochemistry for glial fibrillary acidic protein and epithelial membrane antigen and ultrastructural study confirmed the ependymal nature of tumor cells. The histopathological spectrum of anaplastic ependymoma is very wide and reflects the basically dual characteristics of ependymal cells: epithelial and glial phenotypes. The present case indicates that some anaplastic ependymomas strongly express the glial phenotype and also show remarkable anaplastic cytological features, thus closely simulating glioblastoma. The diagnostic criteria for anaplastic ependymoma, and the nosological position of highly anaplastic ependymoma and its possible clinical implications, are briefly discussed.

Citing Articles

Nomogram incorporating preoperative MRI-VASARI features for differentiating intracranial extraventricular ependymoma from glioblastoma.

Yao Y, Fu Y, Zhou G, Wang X, Li L, Mao Y Quant Imaging Med Surg. 2024; 14(3):2255-2266.

PMID: 38545063 PMC: 10963811. DOI: 10.21037/qims-23-1148.


Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline.

Lim-Fat M, MacDonald M, LaPointe S, Climans S, Cacciotti C, Chahal M Front Oncol. 2022; 12:960509.

PMID: 36249063 PMC: 9559579. DOI: 10.3389/fonc.2022.960509.


Developing a Radiomics Signature for Supratentorial Extra-Ventricular Ependymoma Using Multimodal MR Imaging.

Safai A, Shinde S, Jadhav M, Chougule T, Indoria A, Kumar M Front Neurol. 2021; 12:648092.

PMID: 34367044 PMC: 8339322. DOI: 10.3389/fneur.2021.648092.


Found at Old Age and Continuously Growing WHO Grade II Fourth Ventricle Ependymoma: A Case Report.

Park M, Hong E, Lee S, Gwak H Brain Tumor Res Treat. 2019; 7(2):141-146.

PMID: 31686446 PMC: 6829090. DOI: 10.14791/btrt.2019.7.e32.


Five hTRPA1 Agonists Found in Indigenous Korean Mint, Agastache rugosa.

Moon H, Kim M, Son H, Kweon H, Kim J, Kim Y PLoS One. 2015; 10(5):e0127060.

PMID: 25978436 PMC: 4433173. DOI: 10.1371/journal.pone.0127060.

References
1.
Korshunov A, Neben K, Wrobel G, Tews B, Benner A, Hahn M . Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. Am J Pathol. 2003; 163(5):1721-7. PMC: 1892422. DOI: 10.1016/S0002-9440(10)63530-4. View

2.
Hamilton R, Pollack I . The molecular biology of ependymomas. Brain Pathol. 1997; 7(2):807-22. PMC: 8098521. DOI: 10.1111/j.1750-3639.1997.tb01066.x. View

3.
Rushing E, Brown D, Hladik C, Risser R, Mickey B, White 3rd C . Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Mod Pathol. 1998; 11(5):464-70. View

4.
Kurt E, Zheng P, Hop W, van der Weiden M, Bol M, van den Bent M . Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas. Cancer. 2005; 106(2):388-95. DOI: 10.1002/cncr.21608. View

5.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View